Canaccord Genuity Maintains a 'Buy' on Hologic (HOLX); Now Largest Pure-Play in Molecular Diagnostics With GPRO Acquisition

Go back to Canaccord Genuity Maintains a 'Buy' on Hologic (HOLX); Now Largest Pure-Play in Molecular Diagnostics With GPRO Acquisition